A study being conducted by Dr. Jean Tang of Stanford University School of Medicine, and published in the peer-reviewed journal Cancer, shows that women who take aspirin may reduce the risk of melanoma. Furthermore, the study shows the longer women take aspirin, the lower the risk is for developing melanoma.
Researchers reviewed almost 60,000 Caucasian women and found that those women taking asprin had a 21% lower chance of melanoma, and the longer they took it, the risk dropped by 11% if they took aspirin for 1-4 years, and the risk dropped another 11% if they took it for 5 or more years.
Since aspirin reduces inflammation researchers think this may be the reason why the melanoma risk decreases.
For the full article, visit http://www.aalatimes.com/2013/03/12/aspirin-may-lower-melanoma-risk/.
Researchers reviewed almost 60,000 Caucasian women and found that those women taking asprin had a 21% lower chance of melanoma, and the longer they took it, the risk dropped by 11% if they took aspirin for 1-4 years, and the risk dropped another 11% if they took it for 5 or more years.
Since aspirin reduces inflammation researchers think this may be the reason why the melanoma risk decreases.
For the full article, visit http://www.aalatimes.com/2013/03/12/aspirin-may-lower-melanoma-risk/.
No comments:
Post a Comment